Neuralink Raises $600 Million, Valued at $9 Billion Ahead of FDA-Backed Brain Implant Tests

Neuralink Raises $600 Million, Valued at $9 Billion Ahead of FDA-Backed Brain Implant Tests

Last Updated May - 28 - 2025, 04:03 PM | Source : Fela News

Elon Musk’s Neuralink secures $600 million funding, boosting its valuation to $9 billion. The company advances brain implant technology aimed at aiding spinal c

Elon Musk’s brain implant company Neuralink has secured $600 million in funding, valuing the company at $9 billion before this new investment, according to Semafor, which cited sources familiar with the matter. Neuralink did not immediately respond to requests for comment from Reuters. In 2023, the company was valued at around $5 billion based on private stock trades reported to Reuters. Previously, Neuralink raised $280 million in a round led by Peter Thiel’s Founders Fund.

In April, Bloomberg reported that Neuralink planned to raise approximately $500 million.

Neuralink is currently testing its brain implant designed to assist people with spinal cord injuries. The device has enabled its first patient to play video games, browse the internet, post on social media, and control a laptop cursor using only brain signals.

Earlier this month, the U.S. Food and Drug Administration granted Neuralink’s device a “breakthrough” designation.

Musk has ambitious plans for Neuralink’s technology, envisioning that both healthy and disabled individuals could easily get the implants at local clinics for rapid procedures aimed at treating conditions like obesity, autism, depression, and schizophrenia. He also envisions the chip being used for activities like web browsing and telepathic communication.

Share :